cingal — NDA/BLA submission
2026
Cingal and Hyalofast remain core strategic priorities for 2026 as we prepare for future U.S. market launches.Source filing
catalyst calendar
ANIKA THERAPEUTICS INC · Data as of 2026-10-25
2026
Cingal and Hyalofast remain core strategic priorities for 2026 as we prepare for future U.S. market launches.Source filing